论文部分内容阅读
目的探讨吉西他滨联合~(125)I放射性粒子植入治疗老年非小细胞肺癌的临床疗效。方法回顾性分析笔者所在医院收治的非小细胞肺癌患者的临床资料,依据治疗方式不同分为观察组和对照组。结果观察组近期疗效和远期生存率均明显高于对照组,差异均有统计学意义(P<0.05)。结论吉西他滨联合~(125)I放射性粒子植入治疗老年非小细胞肺癌临床疗效较好,值得临床推广应用。
Objective To investigate the clinical efficacy of gemcitabine combined with 125 I radioactive seed implantation in the treatment of elderly non-small cell lung cancer. Methods The clinical data of patients with non-small cell lung cancer treated in our hospital were retrospectively analyzed. According to the different treatment methods, the patients were divided into observation group and control group. Results The curative effect and long-term survival rate of the observation group were significantly higher than those of the control group, the differences were statistically significant (P <0.05). Conclusion Gemcitabine combined with ~ (125) I radioactive seed implantation in the treatment of elderly non-small cell lung cancer has good curative effect and is worthy of clinical application.